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Background: Transcatheter aortic valve implantation (TAVI) is an emerging treatment option for high-risk patients with aortic stenosis. Since TAVI 
requires intra-arterial administration of contrast media and since impairment of renal function is often pre-existent in the elderly TAVI patients, this 
procedure seems prone to post-procedural development of acute renal failure (ARF), which may adversely affect patient outcome.
Methods: We retrospectively analyzed the risk and short-term outcome of ARF in a cohort of 120 consecutive TAVI patients, 80 of them undergoing 
transfemoral TAVI (Edwards Sapien: n=54, Medtronic / CoreValve: n=26) and 40 transapical TAVI.
Results: TAVI was successful in 99% of patients. ARF according to the RIFLE classification occurred in 41 (34%) patients. There were 19 deaths 
within 30 days accounting for a 30-day-mortality of 15.8%. Subgroup analysis revealed a significantly lower 30-day-mortality in patients without 
post-procedural ARF (4/79 patients, 5.1%) as compared to patients with ARF (15/41 patients, 36.6%, p=0.002). Figure 1
Conclusions: In our preliminary experience, one third of patients undergoing TAVI developed post-procedural ARF which was associated with a 
worse outcome compared to patients who did not develop ARF. Hence, pre- and intraoperative strategies to lower the risk of postprocedural ARF after 
TAVI (e.g. sufficient hydration, limitation of the amount of contrast media) should be taken into consideration.
